Molecular Oncology Department, Moffitt Cancer Center, Tampa, FL, USA.
EMBO J. 2010 Aug 4;29(15):2538-52. doi: 10.1038/emboj.2010.140. Epub 2010 Jun 29.
MDM2 is a key regulator of the p53 tumor suppressor acting primarily as an E3 ubiquitin ligase to promote its degradation. MDM2 also inhibits p53 transcriptional activity by recruiting histone deacetylase and corepressors to p53. Here, we show that immunopurified MDM2 complexes have significant histone H3-K9 methyltransferase activity. The histone methyltransferases SUV39H1 and EHMT1 bind specifically to MDM2 but not to its homolog MDMX. MDM2 mediates formation of p53-SUV39H1/EHMT1 complex capable of methylating H3-K9 in vitro and on p53 target promoters in vivo. Furthermore, MDM2 promotes EHMT1-mediated p53 methylation at K373. Knockdown of SUV39H1 and EHMT1 increases p53 activity during stress response without affecting p53 levels, whereas their overexpression inhibits p53 in an MDM2-dependent manner. The p53 activator ARF inhibits SUV39H1 and EHMT1 binding to MDM2 and reduces MDM2-associated methyltransferase activity. These results suggest that MDM2-dependent recruitment of methyltransferases is a novel mechanism of p53 regulation through methylation of both p53 itself and histone H3 at target promoters.
MDM2 是 p53 肿瘤抑制因子的关键调节因子,主要作为 E3 泛素连接酶促进其降解。MDM2 还通过募集组蛋白去乙酰化酶和核心抑制物到 p53 来抑制 p53 的转录活性。在这里,我们表明免疫纯化的 MDM2 复合物具有显著的组蛋白 H3-K9 甲基转移酶活性。组蛋白甲基转移酶 SUV39H1 和 EHMT1 特异性结合 MDM2,但不结合其同源物 MDMX。MDM2 介导形成 p53-SUV39H1/EHMT1 复合物,能够在体外和体内 p53 靶启动子上甲基化 H3-K9。此外,MDM2 促进 EHMT1 介导的 p53 在 K373 上的甲基化。SUV39H1 和 EHMT1 的敲低在应激反应中增加 p53 活性而不影响 p53 水平,而它们的过表达以 MDM2 依赖的方式抑制 p53。p53 激活物 ARF 抑制 SUV39H1 和 EHMT1 与 MDM2 的结合,并降低 MDM2 相关的甲基转移酶活性。这些结果表明,MDM2 依赖性招募甲基转移酶是通过 p53 自身和靶启动子处的组蛋白 H3 甲基化来调节 p53 的一种新机制。